# Molecular Stethoscope

**Canonical:** https://apis.io/providers/molecular-stethoscope/  
**Website:** https://www.superfluiddx.com/  
**APIs profiled:** 0

Molecular Stethoscope (now operating as Superfluid Dx, Inc.) is a South San Francisco clinical-stage diagnostics company developing minimally invasive blood tests for neurodegenerative disease. Its cell-free messenger RNA (cf-mRNA) liquid-biopsy platform aims to detect Alzheimer's disease at early stages from a routine blood draw, as an alternative to spinal taps and brain imaging. Surfaced as a portfolio company of dcvc and added to the API Evangelist network. As a clinical diagnostics R&D company it publishes no public developer API, documentation, or technical platform; this profile is maintained for network completeness rather than API discovery.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Diagnostics, Healthcare, Life Sciences, Alzheimers, Liquid Biopsy, Biotechnology

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/molecular-stethoscope/). Scores are computed from the provider's own public artifacts under a published rubric.